Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BioSante Pharmaceuticals, Inc.
Paper in Journal of Sexual Medicine Cites Need for FDA-Approved Testosterone Treatment to Replace Growing Off-Label Use
July 9th, 2009
A study to be published in the July 2009 issue of The Journal of Sexual Medicine reports that U.S. physicians wrote two million prescriptions a year for testosterone in 2006 and 2007, representing a significant increase since 2004. Importantly, 21% of the prescriptions written for male testosterone products were for women. Furthermore, the article notes that these statistics do not include the large number of prescriptions written for compounded testosterone formulations, a practice that has been criticized by the American Medical Association and the American College of Obstetrics and Gynecology, among others. In their paper "Approved Hormonal Treatment for HSDD: An...
Source: Women's Health Weekly (2009-07-09)
|
